These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2568378)

  • 1. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics.
    Rey MJ; Schulz P; Costa C; Dick P; Tissot R
    Int Clin Psychopharmacol; 1989 Apr; 4(2):95-104. PubMed ID: 2568378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the dosage of neuroleptics. II: Changing from daily oral to long acting injectable neuroleptics.
    Schulz P; Rey MJ; Dick P; Tissot R
    Int Clin Psychopharmacol; 1989 Apr; 4(2):105-14. PubMed ID: 2568377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?
    Rijcken CA; Monster TB; Brouwers JR; de Jong-van den Berg LT
    J Clin Psychopharmacol; 2003 Dec; 23(6):657-9. PubMed ID: 14624195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the dosage of antipsychotic drugs.
    Beckmann H; Laux G
    Acta Psychiatr Scand Suppl; 1990; 358():63-6. PubMed ID: 1978493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative doses and costs of antipsychotic medication.
    Davis JM
    Arch Gen Psychiatry; 1976 Jul; 33(7):858-61. PubMed ID: 8024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
    Preskorn SH
    J Psychiatr Pract; 2005 Jul; 11(4):258-61. PubMed ID: 16041236
    [No Abstract]   [Full Text] [Related]  

  • 7. Passive and iontophoretic transdermal penetration of chlorpromazine.
    Alvarez-Figueroa MJ; González-Aramundiz JV
    Pharm Dev Technol; 2008; 13(4):271-5. PubMed ID: 18649217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid tranquilization: a reevaluation.
    Solano OA; Sadow T; Ananth J
    Neuropsychobiology; 1989; 22(2):90-6. PubMed ID: 2577117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are chlorpromazine dose equivalents equivalent in serum?
    Rosenblatt JE; Wyatt RJ
    J Clin Psychopharmacol; 1981 Mar; 1(2):91-3. PubMed ID: 6117580
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.
    Barr AM; Honer WG; Johnson JL; Wu TK; Procyshyn RM
    J Clin Psychopharmacol; 2010 Dec; 30(6):741-3. PubMed ID: 21057241
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.
    Bollini P; Pampallona S; Orza MJ; Adams ME; Chalmers TC
    Psychol Med; 1994 May; 24(2):307-16. PubMed ID: 7916157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
    Nosè M; Tansella M; Thornicroft G; Schene A; Becker T; Veronese A; Leese M; Koeter M; Angermeyer M; Barbui C
    Int Clin Psychopharmacol; 2008 Sep; 23(5):287-90. PubMed ID: 18703938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic drug utilisation for acute schizophrenia.
    Razali MS; Hasanah CI
    Singapore Med J; 1996 Dec; 37(6):611-3. PubMed ID: 9104062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid parenteral treatment of acute psychosis.
    Menuck M; Voineskos G
    Compr Psychiatry; 1981; 22(4):351-61. PubMed ID: 6114808
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of antipsychotic drug doses.
    Galletly CA
    Aust Clin Rev; 1991; 11():74-6. PubMed ID: 8634034
    [No Abstract]   [Full Text] [Related]  

  • 18. Antinuclear antibodies in chronic psychotic patients treated with chlorpromazine.
    Quismorio FP; Bjarnason DF; Kiely WF; Dubois EL; Friou GJ
    Am J Psychiatry; 1975 Nov; 132(11):1204-6. PubMed ID: 52302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment strategies of psychotic states using low-dose neuroleptics: immediate and long-term course].
    Schmitt L; Lemaire A; Lefranc G; Febrer A; Moron P
    Ann Med Psychol (Paris); 1988; 146(1-2):119-23. PubMed ID: 2901243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic dosing patterns for schizophrenia in three treatment settings.
    Remington G; Shammi CM; Sethna R; Lawrence R
    Psychiatr Serv; 2001 Jan; 52(1):96-8. PubMed ID: 11141536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.